Literature DB >> 11733015

The regulatory subunit of a cGMP-regulated protein kinase A of Trypanosoma brucei.

T Shalaby1, M Liniger, T Seebeck.   

Abstract

This study reports the identification and characterization of the regulatory subunit, TbRSU, of protein kinase A of the parasitic protozoon Trypanosoma brucei. TbRSU is coded for by a single copy gene. The protein contains an unusually long N-terminal domain, the pseudosubstrate site involved in binding and inactivation of the catalytic subunit, and two C-terminally located, closely spaced cyclic nucleotide binding domains. Immunoprecipitation of TbRSU coprecipitates a protein kinase activity with the characteristics of protein kinase A: it phosphorylates a protein kinase specific substrate, and it is strongly inhibited by a synthetic protein kinase inhibitor peptide. Unexpectedly, this kinase activity could not be stimulated by cAMP, but by cGMP only. Binding studies with recombinant cyclic nucleotide binding domains of TbRSU confirmed that both domains bind cGMP with Kd values in the lower micromolar range, and that up to a 100-fold excess of cAMP does not compete with cGMP binding.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11733015     DOI: 10.1046/j.0014-2956.2001.02564.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  15 in total

1.  A novel protein kinase localized to lipid droplets is required for droplet biogenesis in trypanosomes.

Authors:  John A Flaspohler; Bryan C Jensen; Tracy Saveria; Charles T Kifer; Marilyn Parsons
Journal:  Eukaryot Cell       Date:  2010-09-10

2.  The gene product of a Trypanosoma equiperdum ortholog of the cAMP-dependent protein kinase regulatory subunit is a monomeric protein that is not capable of binding cyclic nucleotides.

Authors:  José Bubis; Juan Carlos Martínez; Maritza Calabokis; Joilyneth Ferreira; Carlos E Sanz-Rodríguez; Victoria Navas; José Leonardo Escalona; Yurong Guo; Susan S Taylor
Journal:  Biochimie       Date:  2017-12-27       Impact factor: 4.079

3.  Independent analysis of the flagellum surface and matrix proteomes provides insight into flagellum signaling in mammalian-infectious Trypanosoma brucei.

Authors:  Michael Oberholzer; Gerasimos Langousis; HoangKim T Nguyen; Edwin A Saada; Michelle M Shimogawa; Zophonias O Jonsson; Steven M Nguyen; James A Wohlschlegel; Kent L Hill
Journal:  Mol Cell Proteomics       Date:  2011-06-19       Impact factor: 5.911

4.  Quantitative proteomic and phosphoproteomic analysis of Trypanosoma cruzi amastigogenesis.

Authors:  Rayner M L Queiroz; Sébastien Charneau; Samuel C Mandacaru; Veit Schwämmle; Beatriz D Lima; Peter Roepstorff; Carlos A O Ricart
Journal:  Mol Cell Proteomics       Date:  2014-09-15       Impact factor: 5.911

Review 5.  Signaling pathways involved in environmental sensing in Trypanosoma cruzi.

Authors:  Noelia Lander; Miguel A Chiurillo; Roberto Docampo
Journal:  Mol Microbiol       Date:  2020-10-25       Impact factor: 3.501

6.  Comparative analysis of the kinomes of three pathogenic trypanosomatids: Leishmania major, Trypanosoma brucei and Trypanosoma cruzi.

Authors:  Marilyn Parsons; Elizabeth A Worthey; Pauline N Ward; Jeremy C Mottram
Journal:  BMC Genomics       Date:  2005-09-15       Impact factor: 3.969

Review 7.  cAMP signalling in trypanosomatids: role in pathogenesis and as a drug target.

Authors:  Laura Makin; Eva Gluenz
Journal:  Trends Parasitol       Date:  2015-05-21

Review 8.  Evolution of the eukaryotic protein kinases as dynamic molecular switches.

Authors:  Susan S Taylor; Malik M Keshwani; Jon M Steichen; Alexandr P Kornev
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-09-19       Impact factor: 6.237

9.  Effects of cyclic nucleotides on midgut infections and maturation of T. b. brucei in G. m. morsitans.

Authors:  Ewan T Macleod; Ian Maudlin; Susan C Welburn
Journal:  Parasit Vectors       Date:  2008-03-14       Impact factor: 3.876

Review 10.  The ever unfolding story of cAMP signaling in trypanosomatids: vive la difference!

Authors:  Daniel N A Tagoe; Titilola D Kalejaiye; Harry P de Koning
Journal:  Front Pharmacol       Date:  2015-09-07       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.